NCT02347228 2024-01-26
Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies
Oneness Biotech Co., Ltd.
Phase 1 Unknown
Oneness Biotech Co., Ltd.
Athenex, Inc.
Royal Marsden NHS Foundation Trust